Brief: Northwest Biotherapeutics says registered direct offering of up to $27.6 mln with existing institutional investors
29/02/2016 15:58
Feb 29 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * Nw bio announces registered direct offering of up to $27.6 million with existing institutional investors * Will immediately sell about 5.88 million shares of common stock at a purchase price of $1.70 per share * Source text for Eikon ID:nPn2F5M6S * Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB